B Prox 10 Anti-blemish Wash, (Benzoyl peroxide 10%), 200 mL bottles, Dermatologic Cosmetic Labora...

FDA Drug Recall #D-0811-2018 — Class II — May 4, 2018

Recall Summary

Recall Number D-0811-2018
Classification Class II — Moderate risk
Date Initiated May 4, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Milbar Laboratories, Inc.
Location East Haven, CT
Product Type Drugs
Quantity 3,477 plastic bottles

Product Description

B Prox 10 Anti-blemish Wash, (Benzoyl peroxide 10%), 200 mL bottles, Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA

Reason for Recall

Microbial Contamination of Non-sterile Product

Distribution Pattern

Within the United States and Puerto Rico

Lot / Code Information

Lot: # ET507-0, Exp. 5/27/2019; GU894-8, Exp. 7/20/2010

Other Recalls from Milbar Laboratories, Inc.

Recall # Classification Product Date
D-0084-2021 Class II DCL B Prox10 Anti-Blemish Wash (Benzoyl Peroxid... Oct 9, 2020
D-0087-2021 Class II DCL T Shampoo for Hair and Body ( Solution Coal... Oct 9, 2020
D-0096-2021 Class II Salicylic Acid Shampoo 3%, Bulk Product, 360 Th... Oct 9, 2020
D-0090-2021 Class II (Malin+Goetz) spf 30 face moisturizer (Avobenzo... Oct 9, 2020
D-0093-2021 Class II Willa Pore Perfector (Salicylic Acid 2%) pads, ... Oct 9, 2020

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.